Equities

Enhabit Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Enhabit Inc

Actions
Health CareHealth Care Providers
  • Price (USD)11.11
  • Today's Change-0.055 / -0.49%
  • Shares traded69.33k
  • 1 Year change+27.64%
  • Beta1.2383
Data delayed at least 15 minutes, as of Feb 17 2026 15:57 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.

  • Revenue in USD (TTM)1.05bn
  • Net income in USD-11.90m
  • Incorporated2014
  • Employees10.70k
  • Location
    Enhabit Inc6688 N. Central Expressway, Suite 1300DALLAS 75206United StatesUSA
  • Phone+1 (469) 621-6419
  • Fax+1 (302) 655-5049
  • Websitehttps://www.ehab.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Burning Rock Biotech Ltd (ADR)78.07m-17.55m313.53m674.00--3.94--4.02-1.68-1.687.327.390.60022.412.79115,823.90-13.50-37.64-18.61-45.8173.0269.83-22.48-124.322.91--0.0036---4.026.2146.97---33.43--
Viemed Healthcare Inc254.79m13.61m314.79m1.18k24.972.367.601.240.33160.33166.203.511.3722.409.36216,110.307.5210.849.7313.4957.8960.945.498.631.0118.030.1350.0022.5422.829.985.7323.06--
QDM International Inc13.95m4.96m391.39m9.0078.3839.4578.3628.060.57840.57841.631.151.34--23.191,549,779.0047.60--68.92--54.82--35.55----1,015.150.00--31.65--208.29------
Community Health Systems Inc12.64bn329.00m473.74m60.00k1.41--0.50610.03752.432.4394.47-10.720.93166.056.02210,733.303.601.074.491.3484.7883.873.861.311.321.331.100.001.15-0.8877-287.97---3.85--
Charming Medical Ltd6.22m1.20m497.22m49.00414.6810,097.79339.9779.920.07080.07080.36730.0029------126,974.50--------99.75--19.27--0.675--0.8968--3.43--54.16------
Enhabit Inc1.05bn-11.90m564.78m10.70k--0.996336.910.539-0.2476-0.247620.6011.200.8275--6.9997,925.23-0.7976---0.9216--48.9850.47-0.9639-1.55--1.350.4371---1.10-1.07-94.04---20.68--
AMN Healthcare Services Inc2.72bn-275.54m624.22m2.97k--0.9666--0.2298-7.20-7.2070.7316.811.13--5.65915,401.90-11.466.72-14.718.9729.3732.55-10.144.92--0.7960.56790.00-21.266.07-169.76--17.28--
Talkspace Inc214.59m4.24m624.52m521.00159.615.7195.802.910.02360.02361.200.66081.61--17.50411,886.803.17-28.333.71-34.2443.2752.111.98-28.25----0.00--25.0237.49105.98--108.54--
Sonida Senior Living Inc375.42m-52.14m640.61m3.42k--21.55594.251.71-2.88-2.8820.764.310.4548--14.61109,931.80-5.88-6.59-6.63-8.36-----12.94-17.54---0.39430.8879--19.19-7.4170.94--4.39--
Omada Health Inc232.34m-26.19m654.94m859.00--3.01--2.82-0.4679-0.46794.133.75------273,665.50--------64.31---11.27--3.59-745.000.00--38.29--30.18------
Nutex Health Inc981.20m120.57m705.14m880.005.852.172.480.718717.0417.04147.1645.931.40162.974.261,226,495.0037.53-32.1452.14-41.1355.0125.9826.83-41.433.1816.100.4267--93.80222.94213.78--93.93--
Fulgent Genetics Inc315.55m-42.98m724.28m1.31k--0.6421--2.30-1.40-1.4010.2836.490.2578--4.91240,326.70-3.6112.18-3.8213.3041.2464.76-14.0024.57----0.00260.00-1.9954.1974.55--102.57--
Teladoc Health Inc2.53bn-223.59m824.68m5.50k--0.59246.100.3262-1.28-1.2814.457.850.789219.8611.96459,672.50-6.98-33.76-8.82-35.2769.8069.21-8.84-147.542.60--0.4166---1.2635.95-354.35--62.64--
Data as of Feb 17 2026. Currency figures normalised to Enhabit Inc's reporting currency: US Dollar USD

Institutional shareholders

48.81%Per cent of shares held by top holders
HolderShares% Held
8 Knots Management LLCas of 31 Dec 20255.08m10.05%
BlackRock Fund Advisorsas of 31 Dec 20253.40m6.71%
The Vanguard Group, Inc.as of 31 Dec 20252.92m5.77%
AREX Capital Management LPas of 30 Sep 20252.49m4.92%
JANA Partners Management LPas of 30 Sep 20252.14m4.22%
UBS Securities LLCas of 31 Dec 20251.96m3.87%
Systematic Financial Management LPas of 31 Dec 20251.90m3.76%
Paradice Investment Management LLCas of 31 Dec 20251.64m3.25%
Dimensional Fund Advisors LPas of 31 Dec 20251.61m3.17%
LOYS AGas of 30 Jun 20251.56m3.09%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.